CNO

CNO Financial Group, Inc.

9 filings tracked

financialsinsuranceMID ($2B-10B)

Signal Magnitude Chart

bullish

bearish

neutral

Signal Timeline

neutralMay 13

Re-election of the board of directors maintains current management leadership.

management change

20%

bullishMay 13

Successful completion of annual shareholder voting requirements with high approval.

regulatory action

40%

neutralMay 13

Re-election of the board of directors maintains current management leadership.

management change

20%

bullishMay 13

Successful completion of annual shareholder voting requirements with high approval.

regulatory action

40%

bullishMay 7

Net operating income grew 25% year-over-year to $101.3 million.

earnings beat

80%

bullishMay 7

Expense ratio compressed by 100 basis points to 18.9%.

margin expansion

70%

bullishMay 7

Exiting the lower-margin fee services business to focus on core insurance.

divestiture

60%

bearishMay 7

High debt-to-equity ratio of 1.45 and significant unrealized investment losses.

dilution risk

40%

bullishMay 7

Net operating income grew 25% year-over-year to $101.3 million.

earnings beat

80%

bullishMay 7

Expense ratio compressed by 100 basis points to 18.9%.

margin expansion

70%

bullishMay 7

Exiting the lower-margin fee services business to focus on core insurance.

divestiture

60%

bearishMay 7

High debt-to-equity ratio of 1.45 and significant unrealized investment losses.

dilution risk

40%

bullishMay 7

Net operating income grew 25% year-over-year to $101.3 million.

earnings beat

80%

bullishMay 7

Expense ratio compressed by 100 basis points to 18.9%.

margin expansion

70%

bullishMay 7

Exiting the lower-margin fee services business to focus on core insurance.

divestiture

60%

bearishMay 7

High debt-to-equity ratio of 1.45 and significant unrealized investment losses.

dilution risk

40%

bullishMay 7

Net operating income grew 25% year-over-year to $101.3 million.

earnings beat

80%

bullishMay 7

Expense ratio compressed by 100 basis points to 18.9%.

margin expansion

70%

bullishMay 7

Exiting the lower-margin fee services business to focus on core insurance.

divestiture

60%

bearishMay 7

High debt-to-equity ratio of 1.45 and significant unrealized investment losses.

dilution risk

40%

bullishMay 7

Net operating income grew 25% year-over-year to $101.3 million.

earnings beat

80%

bullishMay 7

Expense ratio compressed by 100 basis points to 18.9%.

margin expansion

70%

bullishMay 7

Exiting the lower-margin fee services business to focus on core insurance.

divestiture

60%

bearishMay 7

High debt-to-equity ratio of 1.45 and significant unrealized investment losses.

dilution risk

40%

bullishMay 7

Net operating income grew 25% year-over-year to $101.3 million.

earnings beat

80%

bullishMay 7

Expense ratio compressed by 100 basis points to 18.9%.

margin expansion

70%

bullishMay 7

Exiting the lower-margin fee services business to focus on core insurance.

divestiture

60%

bearishMay 7

High debt-to-equity ratio of 1.45 and significant unrealized investment losses.

dilution risk

40%

bullishMay 7

Net operating income grew 25% year-over-year to $101.3 million.

earnings beat

80%

bullishMay 7

Expense ratio compressed by 100 basis points to 18.9%.

margin expansion

70%

bullishMay 7

Exiting the lower-margin fee services business to focus on core insurance.

divestiture

60%

bearishMay 7

High debt-to-equity ratio of 1.45 and significant unrealized investment losses.

dilution risk

40%

Filing History

8-KMay 13, 2026

The 8-K filing confirms that CNO Financial Group has successfully navigated its 2026 annual meeting, maintaining its leadership structure and auditor relationship. While the surface-level results suggest a clean slate, the tension between the high approval rates and the concentrated 'against' votes reflects a common struggle in the insurance sector between management's growth ambitions and investor demands for tighter governance. The overall impact is neutral to slightly positive, as the company maintains operational stability, though the latent dissent remains a metric for investors to monitor regarding future board stability.

10-QMay 7, 2026

The Q1 2026 filing presents a stark contrast between improving short-term operating metrics and deteriorating long-term balance sheet health. On one hand, CNO's shift toward higher-margin insurance products and the divestiture of fee services have driven a meaningful jump in operating income. The company is successfully extracting more value from its core health and annuity blocks while leveraging a high-interest-rate environment to boost investment income. However, these gains are offset by a mounting mountain of unrealized investment losses and a heavy debt load. The trade-off for investors is now a choice between believing in the operational turnaround and the management's ability to navigate the debt stack, or fearing that a market shock will force the realization of billions in losses. The overall impact of the filing is a transition from a value play based on book value to a speculative play on operational execution and interest rate stability.